Income Statement GoHealth, Inc.

Equities

GOCO

US38046W2044

Multiline Insurance & Brokers

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
1.790 ^USD	+1.99%		-8.21%	-16.74%

17/12	GoHealth Inc - to offer and sale, from time to time 9.6 million shares of class A common stock by selling stockholder - SEC filing	RE
19/11	William Blair Downgrades GoHealth to Market Perform From Outperform	MT

d17ea5203c8310dcf5b291ea6dfede5f.P_7KDLMQesv5bpNRzq6HB2rSKiDXuhDn_y4vUhS5-lU.Zo25RPxgQpuXDdw0h9zATQjrEmLk8XOCt2BiA2TdyiROz7NahFFDjqYD_A

Published financial data: GOHEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	88Cr	106.24Cr	63Cr	73Cr	80Cr
Other Revenues, Total	-	-	-	-	-
Total Revenues	88Cr	106.24Cr	63Cr	73Cr	80Cr
Cost of Goods Sold, Total	20Cr	24Cr	19Cr	16Cr	13Cr
Gross Profit	68Cr	82Cr	44Cr	58Cr	67Cr
Selling General & Admin Expenses, Total	57Cr	78Cr	58Cr	51Cr	54Cr
R&D Expenses	5.93Cr	4.84Cr	4.61Cr	4.33Cr	4.1Cr
Amortization of Goodwill and Intangible Assets - (IS)	9.41Cr	9.41Cr	9.41Cr	9.41Cr	9.41Cr
Other Operating Expenses, Total	72Cr	93Cr	73Cr	64Cr	67Cr
Operating Income	-4.48Cr	-10Cr	-28Cr	-6.9Cr	-61.47L
Interest Expense, Total	-3.3Cr	-3.35Cr	-5.71Cr	-6.95Cr	-7.29Cr
Net Interest Expenses	-3.3Cr	-3.35Cr	-5.71Cr	-6.95Cr	-7.29Cr
Other Non Operating Income (Expenses)	4L	7L	1L	37T	8L
EBT, Excl. Unusual Items	-7.75Cr	-14Cr	-34Cr	-14Cr	-7.82Cr
Restructuring Charges	-	-	-1.22Cr	-	-
Merger & Related Restructuring Charges	-	-	-	-	-9L
Impairment of Goodwill	-	-39Cr	-	-1Cr	-
Asset Writedown	-	-	-2.53Cr	-26.87L	-
Other Unusual Items	-1.97Cr	-1.19Cr	-	-	7.4Cr
EBT, Incl. Unusual Items	-9.72Cr	-53Cr	-38Cr	-15Cr	-50.52L
Income Tax Expense	43T	-24T	8L	2L	22.67L
Earnings From Continuing Operations	-9.72Cr	-53Cr	-38Cr	-15Cr	-73.19L
Net Income to Company	-9.72Cr	-53Cr	-38Cr	-15Cr	-73.19L
Minority Interest	5.29Cr	34Cr	23Cr	8.8Cr	43.91L
Net Income - (IS)	-4.43Cr	-19Cr	-15Cr	-6.33Cr	-29.28L
Preferred Dividend and Other Adjustments	-2.55Cr	-	9L	35.66L	36.61L
Net Income to Common Incl Extra Items	-1.88Cr	-19Cr	-15Cr	-6.68Cr	-65.89L
Net Income to Common Excl. Extra Items	-1.88Cr	-19Cr	-15Cr	-6.68Cr	-65.89L
Per Share Items
Net EPS - Basic	-3.35	-26.8	-17.72	-7.19	-0.66
Basic EPS - Continuing Operations	-3.35	-26.8	-17.72	-7.19	-0.66
Basic Weighted Average Shares Outstanding	56.13L	70.66L	84.45L	92.92L	99.8L
Net EPS - Diluted	-3.35	-26.85	-17.72	-7.19	-0.66
Diluted EPS - Continuing Operations	-3.35	-26.85	-17.72	-7.19	-0.66
Diluted Weighted Average Shares Outstanding	56.13L	70.66L	84.45L	92.92L	99.8L
Normalized Basic EPS	0.81	36.8	1.94	0.16	-4.46
Normalized Diluted EPS	0.81	36.8	1.94	0.16	-4.46
Payout Ratio	-	-	-	-5.64	-
Supplemental Items
EBITDA	5.21Cr	4L	-18Cr	2.9Cr	9.16Cr
EBITA	4.92Cr	-88.38L	-19Cr	2.51Cr	8.79Cr
EBIT	-4.48Cr	-10Cr	-28Cr	-6.9Cr	-61.47L
EBITDAR	5.88Cr	84.7L	-17Cr	3.62Cr	9.79Cr
Total Revenues (As Reported)	88Cr	106.24Cr	63Cr	-	-
Effective Tax Rate - (Ratio)	-0.04	0	-0.2	-0.1	-44.87
Current Domestic Taxes	1L	-22T	1L	11T	4L
Current Foreign Taxes	91T	3L	2L	1L	1L
Total Current Taxes	2L	2L	3L	2L	5L
Deferred Domestic Taxes	-2L	-3L	5L	-	17.18L
Deferred Foreign Taxes	-	-	3T	3T	-
Total Deferred Taxes	-2L	-3L	5L	3T	17.18L
Normalized Net Income	45.22L	26Cr	1.64Cr	14.95L	-4.45Cr
Supplemental Operating Expense Items
Advertising Expense	16Cr	32Cr	18Cr	19Cr	20Cr
Marketing Expenses	2.51Cr	3.97Cr	2.72Cr	1.64Cr	3.37Cr
Selling and Marketing Expenses	37Cr	69Cr	47Cr	41Cr	46Cr
General and Administrative Expenses	20Cr	9.82Cr	12Cr	9.31Cr	8.12Cr
Research And Development Expense From Footnotes	5.93Cr	4.84Cr	4.61Cr	4.33Cr	4.1Cr
Net Rental Expense, Total	67L	80.57L	81.52L	72.84L	62.82L
Imputed Operating Lease Interest Expense	51.06L	39.37L	59.37L	73.57L	68.38L
Imputed Operating Lease Depreciation	15.94L	41.2L	22.15L	-73.31T	-6L
Stock-Based Comp., R&D Exp. (Total)	3.31Cr	37.75L	29.24L	30L	10.41L
Stock-Based Comp., S&M Exp. (Total)	3.75Cr	58.83L	38.71L	26.35L	13.51L
Stock-Based Comp., G&A Exp. (Total)	15Cr	1.76Cr	2.53Cr	1.39Cr	88.89L
Total Stock-Based Compensation	22Cr	2.73Cr	3.21Cr	1.96Cr	1.13Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	14Cr	8.44Cr	1.65Cr	9.08Cr	4.09Cr
Total Cash And Short Term Investments	14Cr	8.44Cr	1.65Cr	9.08Cr	4.09Cr
Accounts Receivable, Total	21Cr	31Cr	38Cr	37Cr	35Cr
Other Receivables	33.95L	-	-	-	-
Total Receivables	22Cr	31Cr	38Cr	37Cr	35Cr
Prepaid Expenses	2.92Cr	3.86Cr	1.8Cr	1.32Cr	1.37Cr
Total Current Assets	39Cr	43Cr	41Cr	48Cr	40Cr
Gross Property Plant And Equipment	2.24Cr	5.81Cr	6.5Cr	7.8Cr	7.68Cr
Accumulated Depreciation	-50.16L	-1.03Cr	-1.83Cr	-2.91Cr	-2.82Cr
Net Property Plant And Equipment	1.74Cr	4.77Cr	4.68Cr	4.88Cr	4.86Cr
Goodwill	39Cr	-	-	-	-
Other Intangibles, Total	69Cr	59Cr	50Cr	40Cr	30Cr
Accounts Receivable Long-Term	62Cr	99Cr	70Cr	58Cr	73Cr
Other Long-Term Assets, Total	20.72L	36.08L	17.21L	22.56L	37.17L
Total Assets	210.88Cr	206.89Cr	165.93Cr	149.96Cr	148.84Cr
Liabilities
Accounts Payable, Total	87.33L	3.98Cr	1.51Cr	1.77Cr	1.46Cr
Accrued Expenses, Total	11Cr	16Cr	18Cr	17Cr	19Cr
Current Portion of Long-Term Debt	41.7L	52.7L	52.7L	7.5Cr	3.95Cr
Current Portion of Leases	3L	62.29L	89.74L	57.97L	57.05L
Finance Division Other Current Liabilities, Total	-	-	-	3.36Cr	-
Unearned Revenue Current, Total	7L	5L	5.06Cr	5.24Cr	8.35Cr
Other Current Liabilities	80.1L	82.41L	1.01Cr	1.41Cr	44.19L
Total Current Liabilities	13Cr	22Cr	27Cr	37Cr	34Cr
Long-Term Debt	40Cr	67Cr	50Cr	42Cr	45Cr
Long-Term Leases	1L	1.98Cr	3.84Cr	3.95Cr	3.49Cr
Deferred Tax Liability Non Current	-	-	-	-	2.24Cr
Other Non Current Liabilities	19Cr	27Cr	26Cr	21Cr	19Cr
Total Liabilities	71Cr	117.64Cr	106.76Cr	104.46Cr	103Cr
Preferred Stock Redeemable	-	-	-	-	-
Preferred Stock Non Redeemable	-	-	-	-	-
Preferred Stock Convertible	-	-	4.93Cr	4.93Cr	5.3Cr
Total Preferred Equity	-	-	4.93Cr	4.93Cr	5.3Cr
Common Stock, Total	32T	32T	2T	2T	2T
Additional Paid In Capital	40Cr	56Cr	63Cr	65Cr	67Cr
Retained Earnings	-1.88Cr	-21Cr	-36Cr	-42Cr	-42Cr
Treasury Stock	-	-	-3L	-26.4L	-41.5L
Comprehensive Income and Other	17T	-59T	-1L	-1L	-2L
Total Common Equity	38Cr	35Cr	27Cr	23Cr	24Cr
Minority Interest	101.87Cr	54Cr	27Cr	17Cr	16Cr
Total Equity	139.92Cr	89Cr	59Cr	45Cr	46Cr
Total Liabilities And Equity	210.88Cr	206.89Cr	165.93Cr	149.96Cr	148.84Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	65.63L	77.61L	89.82L	96.99L	1.04Cr
ECS Total Common Shares Outstanding	56.13L	76.99L	89.5L	96.51L	1.03Cr
Book Value / Share	67.77	45.86	30.03	23.94	23.5
Tangible Book Value	-69Cr	-24Cr	-23Cr	-17Cr	-6.07Cr
Tangible Book Value Per Share	-123.79	-31.38	-25.91	-17.15	-5.89
Total Debt	40Cr	70Cr	56Cr	54Cr	53Cr
Net Debt	26Cr	61Cr	54Cr	45Cr	49Cr
Debt Equivalent Oper. Leases	5.36Cr	6.45Cr	6.52Cr	5.83Cr	5.03Cr
Minority Interest, Total (Incl. Fin. Div)	101.87Cr	54Cr	27Cr	17Cr	16Cr
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.04Cr	1.36Cr	92.28L	1.1Cr	83.85L
Full Time Employees	3.07T	5.45T	2.47T	2.53T	2.26T
Accumulated Allowance for Doubtful Accounts (Supple)	10.45L	6L	89T	27T	1T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-4.43Cr	-19Cr	-15Cr	-6.33Cr	-29.28L
Depreciation & Amortization - CF	28.96L	92.51L	64.45L	38.91L	37.33L
Amortization of Goodwill and Intangible Assets - (CF)	9.41Cr	9.41Cr	9.41Cr	9.41Cr	9.41Cr
Depreciation & Amortization, Total	9.7Cr	10Cr	10Cr	9.79Cr	9.78Cr
Amortization of Deferred Charges, Total - (CF)	40.3L	64.22L	93.96L	1.1Cr	1.7Cr
Asset Writedown & Restructuring Costs	-	39Cr	2.63Cr	1.27Cr	-
Stock-Based Compensation (CF)	22Cr	2.73Cr	2.71Cr	1.95Cr	1.13Cr
Other Operating Activities, Total	-3.49Cr	-33Cr	-22Cr	-8.49Cr	-6.99Cr
Change In Accounts Receivable	-16.47L	-27.58L	1.26Cr	53.86L	-21.68L
Change In Accounts Payable	-53.4L	3.05Cr	-2.48Cr	25.56L	-50.6L
Change in Unearned Revenues	-1.45Cr	-2L	5.01Cr	18.09L	13.17L
Change in Other Net Operating Assets	-33Cr	-33Cr	23Cr	11Cr	-6.9Cr
Cash from Operations	-11Cr	-30Cr	6.09Cr	11Cr	-2.16Cr
Capital Expenditure	-1.45Cr	-1.98Cr	-1.35Cr	-1.37Cr	-1.37Cr
Cash Acquisitions	-	-	-	-	1.75Cr
Cash from Investing	-1.45Cr	-1.98Cr	-1.35Cr	-1.37Cr	38.07L
Long-Term Debt Issued, Total	12Cr	56Cr	-	-	56Cr
Total Debt Issued	12Cr	56Cr	-	-	56Cr
Long-Term Debt Repaid, Total	-41.71L	-30Cr	-16Cr	-1.53Cr	-56Cr
Total Debt Repaid	-41.71L	-30Cr	-16Cr	-1.53Cr	-56Cr
Issuance of Common Stock	86Cr	-	5T	91T	4L
Repurchase of Common Stock	-	-	-3L	-22.95L	-15.1L
Issuance of Preferred Stock	-	-	5Cr	-	-
Preferred Dividends Paid	-	-	-	-35.66L	-
Common & Preferred Stock Dividends Paid	-	-	-	-35.66L	-
Other Financing Activities, Total	-71Cr	-66.23L	-43.38L	-	-3.31Cr
Cash from Financing	26Cr	26Cr	-12Cr	-2.11Cr	-3.2Cr
Foreign Exchange Rate Adjustments	35T	-2L	-2L	42T	-55T
Net Change in Cash	13Cr	-5.99Cr	-6.79Cr	7.43Cr	-4.99Cr
Supplemental Items
Cash Interest Paid	3.27Cr	2.82Cr	5.69Cr	5.53Cr	6.55Cr
Cash Income Tax Paid (Refund)	3L	9L	5L	5L	4L
Levered Free Cash Flow	15Cr	1.73Cr	-9.08Cr	7.87Cr	9.28Cr
Unlevered Free Cash Flow	17Cr	3.6Cr	-5.8Cr	12Cr	13Cr
Change In Net Working Capital	10Cr	1.47Cr	79.18L	-5.05Cr	-2.98Cr
Net Debt Issued / Repaid	11Cr	27Cr	-16Cr	-1.53Cr	22.04L

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-1.51	-3.08	-9.43	-2.73	-0.26
Return on Total Capital	-1.9	-3.8	-12.84	-4.02	-0.39
Return On Equity %	-8.6	-46.62	-50.72	-28.91	-1.6
Return on Common Equity	-3.03	-51.63	-48.13	-26.74	-2.79
Margin Analysis
Gross Profit Margin %	77.3	77.47	70.29	78.36	83.65
SG&A Margin	64.92	73.75	92.61	69.06	67.51
EBITDA Margin %	5.94	0.04	-28.6	3.94	11.47
EBITA Margin %	5.61	-0.83	-29.62	3.41	11
EBIT Margin %	-5.11	-9.68	-44.51	-9.39	-0.77
Income From Continuing Operations Margin %	-11.08	-50.28	-59.58	-20.59	-0.92
Net Income Margin %	-5.05	-17.82	-23.54	-8.61	-0.37
Net Avail. For Common Margin %	-2.14	-17.82	-23.69	-9.1	-0.82
Normalized Net Income Margin	0.52	24.47	2.59	0.2	-5.57
Levered Free Cash Flow Margin	17.19	1.63	-14.37	10.71	11.61
Unlevered Free Cash Flow Margin	19.26	3.39	-9.18	16.19	16.19
Asset Turnover
Asset Turnover	0.47	0.51	0.34	0.47	0.53
Fixed Assets Turnover	74.06	32.65	13.37	15.37	16.39
Receivables Turnover (Average Receivables)	5.15	4.08	1.84	1.95	2.22
Short Term Liquidity
Current Ratio	3.08	1.98	1.56	1.29	1.18
Quick Ratio	2.85	1.8	1.49	1.25	1.14
Operating Cash Flow to Current Liabilities	-0.9	-1.38	0.23	0.29	-0.06
Days Sales Outstanding (Average Receivables)	71.03	89.54	198.23	186.94	164.52
Average Days Payable Outstanding	20.5	37.04	53.48	37.72	45.25
Long Term Solvency
Total Debt/Equity	28.66	78.03	94.21	119.36	115.18
Total Debt / Total Capital	22.28	43.83	48.51	54.41	53.53
LT Debt/Equity	28.34	76.74	91.8	101.6	105.32
Long-Term Debt / Total Capital	22.03	43.11	47.27	46.32	48.94
Total Liabilities / Total Assets	33.65	56.86	64.34	69.66	69.2
EBIT / Interest Expense	-1.36	-3.07	-4.93	-0.99	-0.08
EBITDA / Interest Expense	1.58	0.25	-3.02	0.52	1.34
(EBITDA - Capex) / Interest Expense	1.14	-0.34	-3.26	0.32	1.16
Total Debt / EBITDA	7.7	82.22	-3.23	14.99	5.39
Net Debt / EBITDA	4.93	72.26	-3.14	12.48	4.97
Total Debt / (EBITDA - Capex)	10.67	-61.46	-3	24.13	6.27
Net Debt / (EBITDA - Capex)	6.83	-54.01	-2.91	20.09	5.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	62.62	21.09	-40.54	16.31	8.74
Gross Profit, 1 Yr. Growth %	83.31	21.37	-46.06	29.66	16.08
EBITDA, 1 Yr. Growth %	-5.37	-99.21	-12.35T	-116.03	216.51
EBITA, 1 Yr. Growth %	-7.84	-117.96	2.31T	-113.4	250.76
EBIT, 1 Yr. Growth %	-196.58	129.44	176.08	-75.46	-91.09
Earnings From Cont. Operations, 1 Yr. Growth %	136.68	449.58	-29.54	-59.81	-95.16
Net Income, 1 Yr. Growth %	7.79	327.76	-21.47	-57.46	-95.37
Normalized Net Income, 1 Yr. Growth %	-81.02	5.65T	-93.72	-90.87	-3.07T
Diluted EPS Before Extra, 1 Yr. Growth %	-2.57T	701.5	-33.88	-59.42	-90.82
Accounts Receivable, 1 Yr. Growth %	71.26	42.19	24.2	-2.01	-7.17
Net Property, Plant and Equip., 1 Yr. Growth %	173.75	175.08	-2.03	4.43	-0.41
Total Assets, 1 Yr. Growth %	31.61	-1.89	-19.8	-9.63	-0.74
Tangible Book Value, 1 Yr. Growth %	124.74	-65.24	-4.02	-28.6	-63.36
Common Equity, 1 Yr. Growth %	-55.77	-7.18	-23.89	-14.04	4.69
Cash From Operations, 1 Yr. Growth %	38.07L	161.79	-120.37	79.2	-119.8
Capital Expenditures, 1 Yr. Growth %	81.18	36.34	-31.76	1.63	-0.02
Levered Free Cash Flow, 1 Yr. Growth %	19.85	-88.55	-602.6	-186.69	17.89
Unlevered Free Cash Flow, 1 Yr. Growth %	29.5	-78.72	-257.73	-304.99	8.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	96.94	40.33	-15.15	-16.84	12.46
Gross Profit, 2 Yr. CAGR %	115.06	49.16	-19.08	-16.37	22.68
EBITDA, 2 Yr. CAGR %	31.09	-92.64	86.19	343.06	-28.77
EBITA, 2 Yr. CAGR %	30.8	-65.59	94.98	79.53	-31.45
EBIT, 2 Yr. CAGR %	24.87	48.86	150.38	-17.69	-85.21
Earnings From Cont. Operations, 2 Yr. CAGR %	85.94	260.66	96.78	-46.79	-86.06
Net Income, 2 Yr. CAGR %	25.47	114.73	83.28	-42.2	-85.97
Normalized Net Income, 2 Yr. CAGR %	-49.31	230.34	90.26	-92.43	64.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-	1.31T	129.98	-48.2	-80.7
Accounts Receivable, 2 Yr. CAGR %	110.46	56.13	32.89	10.32	-4.63
Net Property, Plant and Equip., 2 Yr. CAGR %	21.36	174.42	64.16	1.15	1.98
Total Assets, 2 Yr. CAGR %	284.24	13.63	-11.3	-14.86	-5.29
Tangible Book Value, 2 Yr. CAGR %	92.94	-11.61	-42.24	-17.22	-48.85
Common Equity, 2 Yr. CAGR %	42.76	-35.93	-15.95	-19.12	-5.14
Cash From Operations, 2 Yr. CAGR %	358.09	31.47T	-26.98	-39.58	-40.44
Capital Expenditures, 2 Yr. CAGR %	53.42	57.17	-3.54	-16.72	0.8
Levered Free Cash Flow, 2 Yr. CAGR %	-	-62.92	-22.48	108.73	1.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-47.46	-41.46	79.81	49.33
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	67.47	5.4	-5.74	-9.06
Gross Profit, 3 Yr. CAGR %	-	77.72	6.27	-5.31	-6.71
EBITDA, 3 Yr. CAGR %	-	-76.12	33.27	-17.79	296.07
EBITA, 3 Yr. CAGR %	-	-32.52	35.83	-20.14	124.44
EBIT, 3 Yr. CAGR %	-	52.94	82.26	15.44	-60.77
Earnings From Cont. Operations, 3 Yr. CAGR %	-	166.84	109.27	15.89	-76.07
Net Income, 3 Yr. CAGR %	-	88.84	53.56	12.64	-75.09
Normalized Net Income, 3 Yr. CAGR %	-	145.36	-11.76	-30.86	-44.54
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	407.42	29	-70.9
Accounts Receivable, 3 Yr. CAGR %	-	84.74	44.67	20.06	4.15
Net Property, Plant and Equip., 3 Yr. CAGR %	-	59.42	94.67	41.19	0.63
Total Assets, 3 Yr. CAGR %	-	143.76	1.17	-10.74	-10.4
Tangible Book Value, 3 Yr. CAGR %	-	8.98	-9.15	-38.01	-36.91
Common Equity, 3 Yr. CAGR %	-	23.68	-32.14	-15.32	-11.85
Cash From Operations, 3 Yr. CAGR %	-	280.14	2.63T	-1.5	-58.35
Capital Expenditures, 3 Yr. CAGR %	-	47.5	19.01	-1.85	-11.49
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-10.3	-19.54	72.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-23.67	-11.1	52.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	26.57	8.17
Gross Profit, 5 Yr. CAGR %	-	-	-	31.46	12.55
EBITDA, 5 Yr. CAGR %	-	-	-	-0.92	3.73
EBITA, 5 Yr. CAGR %	-	-	-	-2.72	3.32
EBIT, 5 Yr. CAGR %	-	-	-	19.12	-33.26
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	40.01	-29.17
Net Income, 5 Yr. CAGR %	-	-	-	17.61	-41.03
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-38.93	13.29
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	37.23
Accounts Receivable, 5 Yr. CAGR %	-	-	-	50.31	22.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	32.89	50.31
Total Assets, 5 Yr. CAGR %	-	-	-	60.04	-1.46
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-2.37	-27.8
Common Equity, 5 Yr. CAGR %	-	-	-	4.36	-22.41
Cash From Operations, 5 Yr. CAGR %	-	-	-	82.15	490.87
Capital Expenditures, 5 Yr. CAGR %	-	-	-	17.35	11.36
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-5.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-0.17